Medilink West Midlands (MedilinkWM) is proud to announce that one of its newest members, Australian company ‘Orthocell Ltd’ (Orthocell), has just signed its first distribution deal in the UK for its range of dental products.
Orthocell is a regenerative medicine company producing cellular therapies, and collagen scaffolds for the treatment of human tissue injuries and defects. Following the recent EU approval (CE Mark) for the collagen scaffold (CelGroTM), the Company is focussed on driving key opinion led product adoption and sales in dental bone and soft tissue indications. This will be followed by, in the short to medium term, regulatory submissions for the use of CelGroTM in other applications including tendons and ligaments, cartilage, nerve and other soft tissue defects.
This distribution deal initiates Orthocell’s business development plans for the UK. It marks the start of Orthocell Ltd bringing their innovative tissue and bone regeneration products to UK patients and clinicians. The company aims to continue the great success they have achieved in other markets.
Orthocell will first launch ‘CelGroTM’, an off the shelf collagen scaffold which supports soft tissue and bone repair in dental applications.
In March this year, MedilinkWM introduced Orthocell’s European Manager, Kevin Edwards, to Geoff Halligan, a long-established distributor and CEO of Carrera Medical, a subsidiary of their highly regarded dental laboratory here in the heart of Birmingham. Kevin described the year to date as being a busy period with extensive promotion of the exciting dental products from Orthocell. Kevin said “It’s been great to meet such an ambitious and friendly group of people here in the West Midlands, so much so, we have been able to set up this distribution agreement in just under two months. MedilinkWM and the Inward Investment Team of the UK Government have been outstanding in their help and support to Orthocell’.
Kevin Edwards continued, saying, ‘Meeting Geoff Halligan and his business partner Jeff Caddick has been excellent as their knowledge and expertise within the UK dental market is second to none. Orthocell are very happy to have Carrera on board to promote and distribute ‘CelGroTM’.
Jeff Caddick reflected ‘Today marks the official start of what has already proven to be a great relationship established when we met with the Australian Orthocell team including Professor Zheng, the inventor and CSO, Paul Anderson, CEO and Gregor Maier, Sales and Marketing Director. This gave us the confidence required to launch our new Company, Carrera Medical, in order to concentrate on bringing ‘CelGroTM’ to the UK dental industry’.
Geoff Halligan proudly announced to MedilinkWM, ‘Within week one of marketing this amazing new dental game changing product we have secured our first orders and we are in negotiations with a major dental chain. We couldn’t have asked for more!’
Kevin Edwards has advised that Orthocell’s business here in the UK is continuing to develop with assistance from the West Midlands Academic Health Science Network (WMAHSN). Orthocell are in discussions to undertake specialist dental research which will complement and extend the existing data for Orthocell’s range of products as well as those currently in development. Orthocell hopes to make further announcements regarding this work in the near future and would like to acknowledge and thank WMAHSN and MedilinkWM for their support in this region.
MedilinkWM congratulates both Orthocell and Carrera Medical on this excellent start to their business. Following further introductions provided to Orthocell, MedilinkWM are looking forward to announcing additional ground-breaking news on Orthocell and Carrera Medical’s growth and development here in the West Midlands and UK.